id: NEW:dietary_linoleic_acid_intake_to_heart_disease_prevalence
name: Dietary Linoleic Acid (Omega-6) Intake â†’ Coronary Heart Disease Mortality
from_node:
  node_id: NEW:dietary_linoleic_acid_intake
  node_name: Dietary Linoleic Acid (Omega-6) Intake
to_node:
  node_id: heart_disease_prevalence
  node_name: Coronary Heart Disease Mortality
direction: positive
category: behavioral
mechanism_pathway:
- 'Step 1: Dietary substitution of saturated fats with omega-6 linoleic acid (from
  sources like safflower oil and polyunsaturated margarine) increases tissue concentration
  of linoleic acid'
- 'Step 2: Increased linoleic acid may promote oxidation of LDL cholesterol and increase
  oxidative stress, potentially contributing to atherosclerotic plaque instability'
- 'Step 3: Pro-inflammatory metabolites derived from linoleic acid (eicosanoids) may
  enhance inflammatory processes in coronary arteries'
- 'Step 4: These combined effects may accelerate coronary heart disease progression
  and increase mortality risk in individuals with existing coronary disease'
evidence:
  quality_rating: A
  n_studies: 6
  primary_citation: 'Christopher E Ramsden et al. 2013. Use of dietary linoleic acid
    for secondary prevention of coronary heart disease and death: evaluation of recovered
    data from the Sydney Diet Heart Study and updated meta-analysis. BMJ (Clinical
    research ed.).'
  supporting_citations: []
description: Substituting dietary saturated fats with omega-6 linoleic acid (primarily
  from safflower oil) was associated with increased coronary heart disease mortality
  in a randomized controlled trial of men with prior coronary events. The Sydney Diet
  Heart Study showed a 74% increased risk of CHD death in the intervention group.
  An updated meta-analysis of linoleic acid intervention trials showed a non-significant
  trend toward increased CHD mortality (HR 1.33, 95% CI 0.99-1.79, P=0.06), challenging
  the widely held assumption that polyunsaturated fat substitution for saturated fat
  reduces cardiovascular risk.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 1.74
    type: hazard_ratio
    ci_lower: 1.04
    ci_upper: 2.92
  p_value: 0.04
  sample_size: 458
moderators:
- name: Pre-existing coronary heart disease
  direction: strengthens
  strength: strong
  description: The study population consisted of men with recent coronary events (secondary
    prevention), suggesting the harmful effect may be more pronounced in those with
    existing cardiovascular disease
- name: Sex
  direction: strengthens
  strength: moderate
  description: Study limited to men aged 30-59 years; generalizability to women uncertain
